Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (231-240 of 311) with videos related to

Pageof 32
Sort By:
Critical Care (London, England)|May 13, 2022
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trialKlaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011Marius M Hoeper, Stefan Andreas, Andreas Bastian, et al.
The European Respiratory Journal|June 10, 2017
Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experienceKaren M Olsson, Christoph B Wiedenroth, Jan-Christopher Kamp, et al.
The New England Journal of Medicine|December 25, 2015
Selexipag for the Treatment of Pulmonary Arterial HypertensionOlivier Sitbon, Richard Channick, Kelly M Chin, et al.
The Lancet. Respiratory Medicine|October 18, 2016
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION studyMarius M Hoeper, Vallerie V McLaughlin, Joan Albert Barberá, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Plos One|December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial PneumoniasMarius M Hoeper, Juergen Behr, Matthias Held, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 4, 2021
Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation - a retrospective single-center studyHelge Draeger, Jawad Salman, Khalil Aburahma, et al.
The European Respiratory Journal|August 30, 2022
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Pageof 32

Showing results (231-240 of 311) with videos related to

Sort By:
Pageof 32
Critical Care (London, England)|May 13, 2022
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trialKlaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
International Journal of Cardiology|January 7, 2012
Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011Marius M Hoeper, Stefan Andreas, Andreas Bastian, et al.
The European Respiratory Journal|June 10, 2017
Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experienceKaren M Olsson, Christoph B Wiedenroth, Jan-Christopher Kamp, et al.
The New England Journal of Medicine|December 25, 2015
Selexipag for the Treatment of Pulmonary Arterial HypertensionOlivier Sitbon, Richard Channick, Kelly M Chin, et al.
The Lancet. Respiratory Medicine|October 18, 2016
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION studyMarius M Hoeper, Vallerie V McLaughlin, Joan Albert Barberá, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Plos One|December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial PneumoniasMarius M Hoeper, Juergen Behr, Matthias Held, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 4, 2021
Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation - a retrospective single-center studyHelge Draeger, Jawad Salman, Khalil Aburahma, et al.
The European Respiratory Journal|August 30, 2022
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Pageof 32